Key result
Colchicine plus heart failure therapy relieves symptoms at 3 months in effusive-constrictive pericarditis.
Why the study?
Diagnosing constrictive pericarditis is challenging due to overlapping clinical features with pathologies such as cardiac tamponade and restrictive cardiomyopathy.
Case Report (n=1)
No
This case report demonstrates that conservative medical therapy with colchicine can provide symptomatic relief and avoid high-risk repeat surgery in patients with early-onset post-surgical effusive-constrictive pericarditis.
Answers are grounded in this paper and cite their sources.
May support colchicine for symptomatic relief in post-surgical effusive-constrictive pericarditis; leaves open need for prospective validation.
BACKGROUND Constrictive pericarditis is a chronic inflammatory process characterized by fibrosis and impaired ventricular filling. The diagnosis is challenging because of overlapping clinical features with other pathologies such as cardiac tamponade, and restrictive cardiomyopathy. We report a case of effusive-constrictive pericarditis with cardiac tamponade in a patient with a history of multiple myeloma, bone marrow transplantation, and colchicine treatment. CASE REPORT A 62-year-old woman was admitted to a hospital in Germany due to cardiac tamponade secondary to bacterial pericardial effusion that necessitated emergency sternotomy and pericardial washout. After a prolonged and complicated hospital course, she flew back to Orlando and presented on her day of arrival because of progressive dyspnea. A computed tomographic angiogram of the chest ruled out pulmonary embolism but showed a moderate pericardial effusion with a mass effect on the right ventricle showing a recurrent cardiac tamponade. Echocardiography suggested the diagnosis of constrictive pericarditis. Cardiac catheterization showed a mean right atrial pressure of 25 mmHg and a simultaneous left and right ventricular pressure waveform of ventricular interdependence, diagnostic of effusive-constrictive pericarditis. Colchicine, along with heart failure core measures, were started and resulted in symptomatic improvement. Her first pericardial effusion was bacterial, while the second was possibly a consequence of the cardiac surgery. CONCLUSIONS Cardiac catheterization has been the criterion standard for diagnosis of constrictive pericarditis. Colchicine may be curative for individuals exhibiting subacute symptoms. This case highlights the presentation and diagnosis of effusive-constrictive pericarditis, which can be associated with cardiac tamponade.
No takes yet. Share an insight, caveat, or question.
Nuaimi et al. (2024) conducted a case report in Effusive-constrictive pericarditis and cardiac tamponade (n=1). Colchicine and heart failure medical therapy was evaluated on Symptomatic improvement. Colchicine twice daily plus heart failure therapy yielded symptomatic improvement at 3 months in a 62-year-old woman with post-surgical effusive-constrictive pericarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: